LivaNova (NASDAQ:LIVN) Reaches New 52-Week High – Still a Buy?

LivaNova PLC (NASDAQ:LIVN) shares reached a new 52-week high on Tuesday . The company traded as high as $77.80 and last traded at $77.1650, with a volume of 30536 shares changing hands. The stock had previously closed at $74.80.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on LIVN shares. Barclays increased their price target on LivaNova from $73.00 to $76.00 and gave the company an “equal weight” rating in a research note on Thursday, May 7th. Weiss Ratings upgraded LivaNova from a “sell (d+)” rating to a “hold (c)” rating in a research note on Thursday, May 7th. Robert W. Baird dropped their price target on LivaNova from $78.00 to $76.00 and set an “outperform” rating on the stock in a research note on Thursday, May 7th. Needham & Company LLC upped their price objective on LivaNova from $64.00 to $81.00 and gave the company a “buy” rating in a report on Wednesday, February 25th. Finally, Mizuho upped their price objective on LivaNova from $85.00 to $90.00 and gave the company an “outperform” rating in a report on Thursday, May 7th. Six analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $79.38.

LivaNova Trading Up 2.1%

The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.11 and a current ratio of 1.33. The business has a fifty day simple moving average of $67.81 and a 200 day simple moving average of $65.16. The stock has a market capitalization of $4.20 billion, a price-to-earnings ratio of 39.06 and a beta of 0.88.

LivaNova (NASDAQ:LIVN) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.98 EPS for the quarter, beating analysts’ consensus estimates of $0.85 by $0.13. LivaNova had a return on equity of 16.48% and a net margin of 7.48%.The firm had revenue of $362.26 million for the quarter, compared to analyst estimates of $346.05 million. During the same period in the prior year, the firm posted $0.88 EPS. The company’s revenue for the quarter was up 14.3% on a year-over-year basis. LivaNova has set its FY 2026 guidance at 4.200-4.300 EPS. As a group, research analysts expect that LivaNova PLC will post 3.72 EPS for the current year.

Insider Buying and Selling

In other news, Director Francesco Bianchi sold 1,800 shares of the stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $75.75, for a total transaction of $136,350.00. Following the sale, the director directly owned 7,228 shares of the company’s stock, valued at approximately $547,521. This represents a 19.94% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.35% of the stock is currently owned by corporate insiders.

Institutional Trading of LivaNova

Several large investors have recently modified their holdings of the stock. Millennium Management LLC grew its holdings in shares of LivaNova by 17.3% during the 4th quarter. Millennium Management LLC now owns 3,484,082 shares of the company’s stock worth $214,376,000 after purchasing an additional 514,268 shares in the last quarter. Artisan Partners Limited Partnership grew its holdings in shares of LivaNova by 94.5% during the 3rd quarter. Artisan Partners Limited Partnership now owns 2,427,045 shares of the company’s stock worth $127,129,000 after purchasing an additional 1,179,436 shares in the last quarter. Wellington Management Group LLP grew its holdings in shares of LivaNova by 83.5% during the 3rd quarter. Wellington Management Group LLP now owns 2,345,516 shares of the company’s stock worth $122,858,000 after purchasing an additional 1,067,349 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of LivaNova by 1.5% during the 4th quarter. Vanguard Group Inc. now owns 2,332,051 shares of the company’s stock worth $143,491,000 after purchasing an additional 34,812 shares in the last quarter. Finally, AQR Capital Management LLC boosted its stake in LivaNova by 29.9% in the fourth quarter. AQR Capital Management LLC now owns 2,155,142 shares of the company’s stock valued at $132,606,000 after buying an additional 496,165 shares in the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.

About LivaNova

LivaNova plc is a global medical technology company that develops and manufactures products and therapies for the cardiac surgery and neuromodulation markets. Headquartered in London, United Kingdom, and Houston, Texas, LivaNova serves hospitals, clinics and healthcare providers in more than 100 countries. The company’s primary focus lies in advancing patient care through innovations in heart–lung bypass, cardiac preservation, circulatory support and neurostimulation therapies.

The Cardiac Surgery business unit offers a comprehensive portfolio of products used in cardiopulmonary bypass procedures, including oxygenators, heart–lung machines, arterial filters, cannulae and sutureless heart valves.